文献速递创面修复显微修复重建美容整形

纳米脂肪移植:再生医学的未来?文献计量分析与系统综述

Nanofat Grafting: The Future of Regenerative Medicine? A Bibliometric Analysis and Systematic Review of Clinical Applications.
PubMed 文献 · Plast Reconstr Surg · 2026-10-13

本文通过文献计量分析与PRISMA系统综述,分析纳米脂肪研究的演进、证据基础与局限。文献计量纳入286篇出版物,系统综述纳入77项临床研究共2737例患者。纳米脂肪研究自2019年后快速增长,应用集中于瘢痕重塑、面部/皮肤年轻化、创面愈合及眶周年轻化等领域。

要点

  • 纳米脂肪已从机械乳化脂肪产品发展为跨美容、重建与功能适应证的再生平台。
  • 系统综述纳入77项临床研究共2737例患者,其中2304例接受纳米脂肪或机械乳化脂肪干预。
  • 现有证据受限于处理方法、辅助治疗、结局指标与研究设计异质性,需标准化术语与特定适应证对照试验。

核心结论

  • 纳米脂肪研究已快速扩展为异质性的脂肪来源再生领域,当前证据支持广泛的转化兴趣,但仍受方法学异质性限制,需标准化术语、产品表征及适应证特异性对照试验。

研究设计与样本

  • 文献计量分析使用Web of Science核心合集,分析出版趋势、引用指标、主要贡献者与关键词网络。
  • 系统综述基于PRISMA,检索PubMed/MEDLINE、Embase、Scopus和Web of Science,纳入评估纳米脂肪干预的人体临床研究。

主要发现

  • 文献计量检索识别286篇出版物,其中241篇在2013年纳米脂肪引入后发表。
  • 发文量在2019年后显著增加,2025年达到峰值45篇;总被引4320次,H指数37。
  • 中国、美国、意大利、瑞士和德国是主要贡献国家。
  • 系统综述纳入77项临床研究共2737例患者,其中2304例接受纳米脂肪或机械乳化脂肪干预。
  • 临床应用分为八个领域,瘢痕重塑、面部/皮肤年轻化、创面愈合和眶周年轻化是最常见适应证。

临床怎么用

  • 纳米脂肪可用于瘢痕重塑、面部/皮肤年轻化、创面愈合及眶周年轻化等适应证,但需注意处理方法与辅助治疗的异质性。
  • 临床应关注标准化术语与产品表征,并优先参考适应证特异性对照试验证据。

局限性

  • 处理方法、辅助治疗、结局指标和研究设计存在变异性,限制现有证据强度。
  • 需标准化术语、产品表征及适应证特异性对照试验以提升证据质量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nanofat grafting has evolved from a mechanically emulsified adipose-derived product into a regenerative platform used across aesthetic, reconstructive, and functional indications. However, terminology, processing methods, and clinical applications remain heterogeneous. This study combined bibliometric mapping with a systematic review to characterize the evolution, evidence base, and limitations of nanofat research. METHODS: A bibliometric analysis was performed using the Web of Science Core Collection to identify nanofat-related publications relevant to plastic, reconstructive, aesthetic, and regenerative surgery. Publication trends, citation metrics, leading contributors, and keyword networks were analyzed using Bibliometrix and VOSviewer. A separate PRISMA-based systematic review was conducted in PubMed/MEDLINE, Embase, Scopus, and Web of Science to identify human clinical studies evaluating nanofat-based interventions. RESULTS: The bibliometric search identified 286 publications, including 241 after the introduction of nanofat in 2013. Output increased markedly after 2019 and peaked in 2025 with 45 publications. The corpus accumulated 4,320 citations and had an H-index of 37. China, the United States, Italy, Switzerland, and Germany were the leading contributors. The systematic review included 77 clinical studies comprising 2,737 patients, of whom 2,304 received nanofat-based or mechanically emulsified adipose-derived interventions. Clinical applications were grouped into eight domains, with scar remodeling, facial/skin rejuvenation, wound healing, and periorbital rejuvenation representing the most frequent indications. CONCLUSIONS: Nanofat research has expanded rapidly into a heterogeneous adipose-derived regenerative field. Current evidence supports broad translational interest but remains limited by variability in processing methods, adjunctive therapies, outcomes, and study design. Standardized terminology, product characterization, and indication-specific controlled trials are needed.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Caimi E, Ghetti EM, Giovagnoli F, et al. Nanofat Grafting: The Future of Regenerative Medicine? A Bibliometric Analysis and Systematic Review of Clinical Applications. Plast Reconstr Surg. 2026. PMID: 42868659. doi:10.1097/PRS.0000000000013530

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。